Studies of concanavalin A in nonobese diabetic mice. I. Prevention of insulin-dependent diabetes.

Abstract excerpt

Concanavalin A (Con A) administered in vivo inhibited the development of insulin-dependent diabetes mellitus (IDDM) in nonobese diabetic mice. By experimental day 310 only one of 10 Con A-treated animals had developed IDDM compared to six of 11 cohort controls receiving buffered saline and 65% of colony controls. Treatment consisted of an initial 70-day course of Con A at a dose of 10 micrograms/g b. wt., i.p. in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antigens, Differentiation, T-Lymphocyte
• Share to CD4 Antigens